Compare
Odyssey Health, Inc. vs Global Innovative Platforms Inc. vs Vycor Medical Inc vs Mountain Crest Acquisition Corp. V
| Latest fiscal year | Odyssey Health, Inc. ODYY | Global Innovative Platforms Inc. GIPL | Vycor Medical Inc VYCO | Mountain Crest Acquisition Corp. V MCAG |
|---|---|---|---|---|
| Year ended | 2026-07-31 | 2025-09-30 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $0 | $1.86M | n/a |
| Revenue growth (YoY) | n/a | n/a | +17.2% | n/a |
| Gross margin | n/a | n/a | 83.8% | n/a |
| Operating margin | n/a | n/a | 1.8% | n/a |
| Net margin | n/a | n/a | -3.9% | n/a |
| Net income | -$5.73M | -$718.3K | -$72.4K | -$431.2K |
| EPS (Diluted) | -$0.05 | -$0.02 | -$0.01 | n/a |
| Operating cash flow | -$1.05M | -$560.7K | -$13.5K | -$742.0K |
| Free cash flow | n/a | n/a | -$18.7K | n/a |
| Cash & equivalents | n/a | n/a | $87.0K | n/a |
| Total assets | $147.9K | $199.3K | $830.4K | $873.6K |
| Total liabilities | n/a | $11.6K | $4.92M | $3.72M |
| Shareholders' equity | -$12.13M | $187.7K | -$4.09M | -$3.68M |
| Return on year-end equity | n/a | -382.7% | n/a | n/a |
| Shares outstanding | 105.97M | 44.48M | 33.37M | 2.80M |
Revenue, most recent five fiscal years
| Fiscal year | Odyssey Health, Inc. | Global Innovative Platforms Inc. | Vycor Medical Inc | Mountain Crest Acquisition Corp. V |
|---|---|---|---|---|
| Latest | $0 Ended 2020-07-31 | $0 Ended 2025-09-30 | $1.86M Ended 2025-12-31 | n/a |
| 1 year earlier | $0 Ended 2019-07-31 | $0 Ended 2024-09-30 | $1.59M Ended 2024-12-31 | n/a |
| 2 years earlier | $0 Ended 2018-07-31 | $0 Ended 2023-09-30 | $1.46M Ended 2023-12-31 | n/a |
| 3 years earlier | $0 Ended 2017-07-31 | $0 Ended 2022-09-30 | $1.22M Ended 2022-12-31 | n/a |
| 4 years earlier | $37.5K Ended 2016-07-31 | $0 Ended 2021-09-30 | $1.39M Ended 2021-12-31 | n/a |